11.04.2018
- In an all-cash deal expected to close in the second half of this year, Swiss drugs giant Novartis has agreed to pay $8.7 billion for AveXis, a US-based clinical stage gene therapy...
10.04.2018
- Motiva Enterprises, wholly owned by affiliates of Saudi Aramco, has signed Memorandums of Understanding (MoUs) – said to be worth between $8-10 billion – with TechnipFMC and...
10.04.2018
- Biogen and partner Samsung Bioepis have reached agreement with AbbVie regarding the commercialization of Imraldi, their biosimilar form of the latter’s blockbuster Humira. Specific...
10.04.2018
- Johnson & Johnson, the US market’s largest healthcare company, and its talc supply partner Imerys Talc America have lost their first lawsuit involving the deadly cancer...
09.04.2018
- Malaysia’s national oil company Petronas has formed two joint ventures with Saudi Aramco for the Refinery and Petrochemical Integrated Development (RAPID) project in the southern...
09.04.2018
- Ineos said last week it is making progress on its plans announced in September 2017 to build a 300,000 t/y plant for vinyl acetate monomer (VAM) at one of its integrated European...
09.04.2018
- The Chinese government has announced a new pharmaceutical policy that will include tax breaks to promote generics, allow compulsory patent licensing during public health...
08.04.2018
- As the leading international trade fair for analytics, laboratory technology and biotechnology, every two years, the analytica in Munich is the international mainstay of the...
06.04.2018
- Pfizer and Allogene have entered into an agreement to develop allogeneic chimeric antigen receptor T cell (CAR T) therapy for treating cancer. The deal will see Pfizer take a 25%...
06.04.2018
- German specialty chemicals producer Evonik said it has improved both the production process and the quality of the high performance polymer in polyetheretherketone (PEEK) it...
